|
1
|
Ren-an Q, Juan L, Chuyuan L, Wenjuan F,
Chunyan H, Xuemei Y, Lin H and Hong N: Study of the protective
mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against
myocardial ischemia/reperfusion injury via the Akt-eNOS signaling
pathway in rats. J Ethnopharmacol. 156:190–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lopez AD and Murray CC: The global burden
of disease, 1990–2020. Nat Med. 4:1241–1243. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shimokawa H and Yasuda S: Myocardial
ischemia: Current concepts and future perspectives. J Cardiol.
52:67–78. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morgan EN, Boyle EM Jr, Yun W, Kovacich
JC, Canty TG Jr, Chi E, Pohlman TH and Verrier ED:
Platelet-activating factor acetylhydrolase prevents myocardial
ischemia-reperfusion injury. Circulation. 100(19): Suppl.
II365–II368. 1999.PubMed/NCBI
|
|
5
|
Li SY, Wang XG, Ma MM, Liu Y, Du YH, Lv
XF, Zhou JG, Tang YB and Guan YY: Ginsenoside-Rd potentiates
apoptosis induced by hydrogen peroxide in basilar artery smooth
muscle cells through the mitochondrial pathway. Apoptosis.
17:113–120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Li X, Wang X, Lau W, Wang Y, Xing
Y, Zhang X, Ma X and Gao F: Ginsenoside Rd attenuates myocardial
ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition
of the mitochondria-dependent apoptotic pathway. PLoS One.
8:e709562013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu J, Qiu Y, Wang Q, Zhu Y, Hu S, Zheng
L, Wang L and Zhang Y: Low dose cyclophosphamide rescues myocardial
function from ischemia-reperfusion in rats. Eur J Cardiothorac
Surg. 34:661–666. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji XY, Tan BK and Zhu YZ: Salvia
miltiorrhiza and ischemic diseases. Acta Pharmacol Sin.
21:1089–1094. 2000.PubMed/NCBI
|
|
9
|
Dong ZT and Jiang WD: Effect of danshensu
on isolated swine coronary artery perfusion preparation (author's
transl). Yao Xue Xue Bao. 17:226–228. 1982.(In Chinese). PubMed/NCBI
|
|
10
|
Lam FF, Yeung JH, Chan KM and Or PM:
Relaxant effects of danshen aqueous extract and its constituent
danshensu on rat coronary artery are mediated by inhibition of
calcium channels. Vascul Pharmacol. 46:271–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu L, Qiao H, Li Y and Li L: Protective
roles of puerarin and Danshensu on acute ischemic myocardial injury
in rats. Phytomedicine. 14:652–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wong KL, Wu KC, Wu RS, Chou YH, Cheng TH
and Hong HJ: Tetramethylpyrazine inhibits angiotensin II-increased
NAD(P)H oxidase activity and subsequent proliferation in rat aortic
smooth muscle cells. Am J Chin Med. 35:1021–1035. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng L, Ke N, Cheng F, Guo Y, Li S, Li Q
and Li Y: The protective mechanism of ligustrazine against renal
ischemia/reperfusion injury. J Surg Res. 166:298–305. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang XP, Wang C, Wu DJ, Ma ML and Ou JM:
Protective effects of ligustrazine, kakonein and Panax
notoginsenosides on multiple organs in rats with severe acute
pancreatitis. Methods Find Exp Clin Pharmacol. 32:631–644. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang WD, Yang YF, Chen JW and Zhu BH:
Synergism of salviamiltiorriza bunge and tetramethylpyrazine on
cardiovascular system in rat. Chinese Pharmacological Bulletin.
432–436. 2013.(In Chinese).
|
|
16
|
Buerke M, Murohara T, Skurk C, Nuss C,
Tomaselli K and Lefer AM: Cardioprotective effect of insulin-like
growth factor I in myocardial ischemia followed by reperfusion.
Proc Natl Acad Sci USA. 92:8031–8035. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miki T, Miura T, Tsuchida A, Nakano A,
Hasegawa T, Fukuma T and Shimamoto K: Cardioprotective mechanism of
ischemic preconditioning is impaired by postinfarct ventricular
remodeling through angiotensin II type 1 receptor activation. J
Cardiol. 37:112–113. 2001.(In Japanese). PubMed/NCBI
|
|
18
|
Oron U, Yaakobi T, Oron A, Mordechovitz D,
Shofti R, Hayam G, Dror U, Gepstein L, Wolf T, Haudenschild C and
Haim SB: Low-energy laser irradiation reduces formation of scar
tissue after myocardial infarction in rats and dogs. Circulation.
103:296–301. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaminski KA, Bonda TA, Korecki J and
Musial WJ: Oxidative stress and neutrophil activation-the two
keystones of ischemia/reperfusion injury. Int J Cardiol. 86:41–59.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schulz R, Kelm M and Heusch G: Nitric
oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res.
61:402–413. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thirunavukkarasu M, Penumathsa SV, Koneru
S, Juhasz B, Zhan L, Otani H, Bagchi D, Das DK and Maulik N:
Resveratrol alleviates cardiac dysfunction in
streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin,
and heme oxygenase. Free Radic Biol Med. 43:720–729. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vinten-Johansen J, Zhao ZQ, Jiang R, Zatta
AJ and Dobson GP: Preconditioning and postconditioning: Innate
cardioprotection from ischemia-reperfusion injury. J Appl Physiol
(1985). 103:1441–1448. 2007. View Article : Google Scholar : PubMed/NCBI
|
